Common Stock, Shares, Outstanding of Crinetics Pharmaceuticals, Inc. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Crinetics Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • Crinetics Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 95,575,000, a 2.9% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Crinetics Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 95,575,000 +2,649,000 +2.9% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 94,548,000 +13,707,000 +17% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 94,126,000 +14,804,000 +19% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 93,525,000 +14,986,000 +19% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 92,926,000 +24,751,000 +36% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 80,841,000 +14,133,000 +21% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 79,322,000 +24,640,000 +45% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 78,539,000 +24,549,000 +45% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 68,175,000 +14,298,000 +27% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 66,708,000 +12,912,000 +24% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 54,682,000 +962,000 +1.8% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 53,990,000 +6,189,000 +13% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 53,877,000 +6,280,000 +13% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 53,796,000 +15,176,000 +39% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 53,720,000 +16,040,000 +43% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 47,801,000 +14,784,000 +45% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 47,597,000 +14,596,000 +44% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 38,620,000 +5,699,000 +17% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 37,680,000 +4,798,000 +15% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 33,017,000 +8,430,000 +34% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 33,001,000 +8,738,000 +36% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 32,921,000 +8,703,000 +36% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 32,882,000 +8,687,000 +36% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 24,587,000 +472,000 +2% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 24,263,000 +24,238,939 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q3 2019 24,218,000 +183,012 +0.76% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 24,195,000 +21,850,638 +932% 30 Jun 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 24,115,000 31 Mar 2019 10-Q 13 May 2019 2019 Q1
Q4 2018 24,061* -1,525,514 31 Dec 2018 10-K 09 Mar 2020 2019 FY
Q3 2018 24,034,988 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 2,344,362 30 Jun 2018 10-Q 30 Aug 2018 2018 Q2
Q4 2017 1,549,575 31 Dec 2017 10-K 13 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.